AZN2 quarters
Position history for
FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in ASTRAZENECA PLC
Yes. Farallon Capital Management holds 574,000 shares of AZN (AstraZeneca), worth $108.8M, as of its Q2 2026 13F filing. It increased the position by 347,501 shares (+153.4%) from Q1 2026. Farallon Capital Management has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.5% of Farallon Capital Management's reported 13F portfolio.
Current Value
$108.8M
Current Shares
574,000
Total Value Change
+$64.2M
Total Shares Change
+347,501
Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK